Clinical Trial Update: Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of radiotherapy and pembrolizumab for Adrenocortical Carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Adrenocortical Carcinoma, ACC | Phase 2 | Status: RECRUITING